Parent-administered pediatric Tuina for attention deficit/hyperactivity disorder symptoms in preschool children: A pilot randomized controlled trial embedded with a process evaluation

Shu-Cheng Chen,Juan Yu,Hao-Sheng Wang,Dong-Dong Wang,Yan Sun,Hui-Lin Cheng,Lorna Kwai-Ping Suen,Wing-Fai Yeung

DOI: https://doi.org/10.1016/j.phymed.2022.154191

IF: 6.656

2022-07-20

Phytomedicine

Abstract:BackgroundBeneficial effects of parent-administered pediatric tuina on ADHD in children have been reported in previous studies, but no rigorously designed randomized controlled trials (RCTs) have been conducted on it.ObjectiveTo assess the feasibility and preliminary effects of parent-administered pediatric tuina for ADHD symptoms in preschoolers.MethodsThis project was a two-arm, parallel, open-label, pilot RCT. Sixty-four participants were randomized into two groups at a 1:1 ratio. Parents in the parent-administered tuina group (n = 32) attended an online training program on pediatric tuina for ADHD and conduct this intervention on their children at home. Parents in the parent–child interaction group (n = 32) attended an online training about progressive muscle relaxation exercise and carried out parent–child interactive physical activities with their children at home. Both interventions were carried out every other day during a two-month intervention period, with each manipulation for at least 20 min. Feasibility outcomes included recruitment rate, consent rate, participants’ adherence, retention rate, and adverse event. Outcomes were assessed at baseline, week 4, and week 8. The primary outcome measure was the Swanson, Nolan, and Pelham parent scale (SNAP); the secondary outcomes included preschool anxiety scale, children's sleep habits questionnaire, and parental stress scale. A mixed-method process evaluation embedded within the outcome evaluation was performed.ResultsThe recruitment rate was 12.8 per month. The consent rate was 98.5%. Good adherence was shown from the parent logbook. Four participants withdraw from the study. No severe adverse event was reported. For the SNAP total score, both groups showed improvement with moderate within-group effect size (Cohen's d > 0.5, all p < 0.001) and the between-group effect size was minimal (dppc2 0.05). Perceived improvements on children's appetite and sleep quality, and parent–child relationship was observed from the qualitative data.ConclusionsThe study design and the parent-administered pediatric tuina intervention were feasible. Parent-administered pediatric tuina provided beneficial effects on improving core hyperactivity/impulsivity symptoms in preschool children. Parents perceived improvements on children's appetite and sleep quality. Further large-scale are warranted.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences